GLOW Protocol
Dosing & Research
Last Updated: September 4, 2026
Also known as: GLOW Protocol, GLOW Blend
GHK-cu/BPC-157/TB-500 blend, Skin repair and remodeling, Soft tissue healing, Recovery protocols
Administration
Subcutaneous
Frequency
Once Daily
How It Works
- GHK-cu/BPC-157/TB-500 blend
- Skin repair and remodeling
- Soft tissue healing
- Recovery protocols
Dosing Structure
Dose
2mg / BPC-157: 400mcg / TB-500: 400mcg daily
Frequency
Once Daily
Notes
GLOW is a blend of GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg) — 70mg total. Daily dose: 2mg GHK-Cu, 400mcg BPC-157, 400mcg TB-500. Reconstitution: 70mg vial mixed with 3ml bacteriostatic water yields approximately 23.3mg/ml (inject ~0.086ml daily). Cycle: 2-3 months on, 1 month break.
Example Protocols
Dose: 2mg / BPC-157: 400mcg / TB-500: 400mcg daily
Frequency: Once Daily
Duration: 2-3 months; 1 month break between cycles
Off Period: Not listed
Find Research Grade GLOW
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
GLOW is a blend of GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg) — 70mg total.
•
Daily dose: 2mg GHK-Cu, 400mcg BPC-157, 400mcg TB-500.
•
Reconstitution: 70mg vial mixed with 3ml bacteriostatic water yields approximately 23.3mg/ml (inject ~0.086ml daily).
•
Cycle: 2-3 months on, 1 month break.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.